Mechanism of shortened bones in mucopolysaccharidosis VII

Keyphrases

• Bone Defect 16%
• Chondrocyte Proliferation 33%
• Chondrocytes 16%
• Chondroitin 4-sulfate 50%
• Fibroblast Growth Factor Receptor 3 (FGFR3) 50%
• Gain-of-function mutation 16%
• Glycosaminoglycans 33%
• Growth Plate 66%
• Interleukin-6 16%
• Janus Kinase 1 (JAK1) 16%
• Janus Kinase 2 (JAK2) 16%
• Leukemia Inhibitory Factor 50%
• Long Bone 33%
• Lysosomal Storage Disease 16%
• Mucopolysaccharidosis VII 100%
• Normal numbers 16%
• Overactivation 16%
• Pro-proliferative 16%
• Reduced Expression 16%
• STAT3 Phosphorylation 16%
• Transcription Factor 16%
• Tyrosine Kinase 2 (TYK2) 16%
• Tyrosine Phosphorylation 50%
• β-glucuronidase 16%

Biochemistry, Genetics and Molecular Biology

• Beta-Glucuronidase 16%
• Chondrocyte 50%
• Chondroitin 50%
• Cytokine 16%
• Deficiency 16%
• Fibroblast Growth Factor Receptor 3 50%
• Glycosaminoglycan 33%
• Interleukin 6 16%
• Janus Kinase 16%
• Janus Kinase 1 16%
• Leukemia Inhibitory Factor 50%
• Loss of Function Mutation 16%
• Lysosomal Storage Disease 16%
• Sly Syndrome 100%
• STAT3 50%
• Sulfate 50%
• Transcription Factors 16%
• Tyrosine Kinase 2 16%
• Tyrosine Phosphorylation 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Beta Glucuronidase 16%
• Bone Defect 16%
• Chondroitin 4 Sulfate 50%
• Cytokine 16%
• Fibroblast Growth Factor Receptor 3 50%
• Glycosaminoglycan 33%
• Interleukin 6 16%
• Janus Kinase 16%
• Janus Kinase 1 16%
• Leukemia Inhibitory Factor 50%
• Lysosome Storage Disease 16%
• Mucopolysaccharidosis Type 7 100%
• Protein Tyrosine Kinase 16%
• Receptor 16%
• Transcription Factors 16%